Immunopathogenesis of psoriasis and its current therapy possibilities;Imunopatogeneze psoriázy a současné možnosti terapie

Ceska a Slovenska Farmacie

Volumn 51, Issue 5, 2002, Pages 213-219

  Svozil, M ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Drugs; Immunology; Pathogenesis; Psoriasis; Therapy

Indexed keywords

CORTICOSTEROID; CYTOKINE; DITHRANOL; PSORALEN; SALICYLIC ACID; TAR; UREA DERIVATIVE; VITAMIN D DERIVATIVE;

IMMUNE SYSTEM; IMMUNOPATHOLOGY; PATHOGENESIS; PHOTOTHERAPY; PSORIASIS; PUVA; REVIEW; ULTRAVIOLET IRRADIATION;

HUMANS; PSORIASIS;

EID: 0036035693     PISSN: 12107816     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Novotný, F.: Remedia 3, 96 (1993).
2. Štáva, Z.: Dermatovenerologie. 1. Vyd., Avicenum, Praha, 25, 210, 216 (1977).
3. Vašků, V.: Causa Subita 4, 165 (2001).
4. Duchková, H.: Psoriáza. Causa Subita 3, 16 (2000).
5. Ettler, K.: Imunologické faktory u psoriázy (souhrn). Lék. zpr. LF UK Hradec Králové 39, 221 (1994).
6. Harvey, B.: Psoriasis. In: Rook, A. et al.: Textbook of Dermatology; 14. vyd. Blackwell Sci. Publ., Oxford 1990, s. 1469-1511.
7. Peters, B. P., Wissmen, F. G., Gill, M. A.: Am. J. Health. Syst. Pharm. 57, 645 (2000).
8. Novotný, F.: Acta Univ, Carol. Med. 32, 175 (1986).
9. Nickoloff, B. J.: Role of cytokines in psoriasis and other T-cell-mediated disease. In: Aggarwal, B. B., Puri, R. K. (Ed.): Human Cytokines: Their Role in Disease and Therapy; 1. vyd., Blackwell Science, Ann Arbor, 1995, s. 642-646.
10. Kemény, L.: Exp. Dermatol. 3, 1 (1994).
11. Halagovec, A., Héjj, F., Baranová, Z.: Čs. Dermatol. 68, 16 (1993).
12. Guzzo, C.: Advan. Clin. Research. 15, 59 (1997).
13. Leung, D. Y. M., Travers, J. B., Norris, D. A.: J. Invest. Dermatol. 105, S37 (1995).
14. Hunziker, T.: Exp. Dermatol. 1, 149 (1992).
15. Šmíd, P., Šeda, O., Záruba, F.: Čs. Dermatol. 64, 184 (1989).
16. Terui, T., Ozawa, M., Tagami, H.: Exp. Dermatol. 9, 1 (2000).
17. Duan, H., Koga, T., Kohda, F.: J. Dermatol. Sci. 26, 119 (2001).
18. Valdimarsson, H.: Immunol. Today 16, 145 (1995).
19. Detmar, M.: Hautarzt 43, 679 (1992).
20. Farber, E. M., Raychaudhuri, S. P.: J. Invest. Dermatol. 38, 16 (1999).
21. Honigsmann, H.: Clin. Exp. Dermatol. 26, 343 (2001).
22. Olaniran, A. K.: Arch. Dermatol. Res. 288, 421 (1996).
23. Prous, J. R.: Antipsoriatics. Year Drug News. Therap. Targets. Prous Sci. Publ., Barcelona 1994, s. 297-300.
24. st World Meeting APGI/APV9/11, s. 713-714, 1995.
25. Anigbogu, A. N. C., Williams, A. C., Barry, B. W.: J. Pharm. Pharmacol. 48, 357 (1996).
26. British National Formulary. 22. Preparations for psoriasis and eczema, Br. Med. Assoc. Royal Pharm. Soc. Great Britain, London 1991, s. 381-385.
27. Novotný, F.: Čs. Dermatol. 71, 176 (1996).
28. Shani, J.: Pharmacol. Commun. 7, 21 (1995).
29. Levi-Schaffer, F.: Pharmacol. 52, 321 (1996).
30. McMichael, A. J.: Br. J. Dermatol. 135, 60 (1996).
31. Swinkels, O. Q., Prins, M., Tosserams, E. F.: Br. J. Dermatol. 145, 63 (2001).
32. Stewart, D. G., Lewis, H. M.: J. Clin. Pharm. Ther. 21, 143 (1996).
33. Zellis, S., Pincus, S.: Miscellaneous agents - Vitamin D (calcipotriol). Basic Clin. Dermatol. In.: Immunomodulatory and cytotoxic agents in dermatology; Dekker, Berlin 1997, s. 157-167.
34. Savoia, P., Novelli, M., De Matteis, A.: J. Cutan. Pathol. 25, 89 (1998).
35. Kang, S., Yi, S., Griffiths, C. E.: Br. J. Dermatol. 138, 77 (1998).
36. Kowalzick, L.: Br. J. Dermatol. 144, 21 (2001).
37. Guilhou, J. J.: Ann. Dermatol. Venereol. 128, 229 (2001).
38. Seidenari, S., Magni, R., Gianetti, A.: Skin Pharmacol. 10, 40 (1997).
39. Gollnick, H., Menke, T.: Curr. Med. Res. Opin. 14, 213 (1998).
40. Kerkhof van de, P. C. M.: Br. J. Dermatol. 135, 758 (1996).
41. Kerkhof van de, P. C. M.: Appl. Skin. Physiol. 14, 129 (2001).
42. Lamba, S., Lebwohl, M.: Br. J. Dermatol. 144, 27 (2001).
43. Berg, M.: Current Ther. Res. 55, 598 (1994).